不同促排卵方案在卵巢储备功能减退患者中的应用研究
Study on the Application of Different Ovulation Induction Regimens in Patients with Diminished Ovarian Reserve
DOI: 10.12677/acm.2026.161031, PDF,   
作者: 黄东识：右江民族医学院临床医学院，广西 百色；韦敬锡*：右江民族医学院附属医院生殖医学中心，广西 百色
关键词: 卵巢储备功能减退；促排卵方案；体外受精–胚胎移植；Diminished Ovarian Reserve； Ovulation Promotion Program； In Vitro Fertilization-Embryo Transfer
摘要: 体外受精–胚胎移植技术已成为解决卵巢储备功能减退患者生育问题的主要途径。目前常应用于临床上的促排卵方案包括拮抗剂方案、GnRH激动剂方案、高孕激素状态下促排卵方案、微刺激方案、自然周期方案等。针对不同的患者，我们选择的促排卵方案也需实现个体化，以尽可能多地获取优质胚胎为目的，助力患者早日受孕，实现受益最大化。本文主要阐述不同促排卵方案在卵巢储备功能减退患者中的应用研究进展，为临床医师制定个体化的促排卵策略提供参考依据。
Abstract: In vitro fertilization-embryo transfer technology has become the main way to solve the fertility problem of patients with diminished ovarian reserve. At present, the ovulation induction schemes commonly used in clinical practice include antagonist scheme, GnRH agonist scheme, ovulation induction scheme under high progesterone state, microstimulation scheme, natural cycle scheme and so on. For different patients, the ovulation induction protocol we choose also needs to be individualized, in order to obtain as many high-quality embryos as possible, to help patients conceive as soon as possible, to maximize clinical outcomes. This article mainly expounds the application research progress of different ovulation induction regimens in patients with diminished ovarian reserve, and provides a reference for clinicians to formulate individualized ovulation induction strategies.
文章引用：黄东识, 韦敬锡. 不同促排卵方案在卵巢储备功能减退患者中的应用研究[J]. 临床医学进展, 2026, 16(1): 214-219. https://doi.org/10.12677/acm.2026.161031

参考文献

[1] 彭婀娜, 艾苗, 谭小军, 等. 单次和双次富血小板血浆治疗卵巢储备功能减退的疗效[J]. 中南大学学报(医学版), 2025, 50(1): 45-51.
[2] Zhu, Q., Li, Y., Ma, J., Ma, H. and Liang, X. (2023) Potential Factors Result in Diminished Ovarian Reserve: A Comprehensive Review. Journal of Ovarian Research, 16, Article No. 208. [Google Scholar] [CrossRef] [PubMed]
[3] Liu, L., Cai, B., Zhang, X., Tan, J., Huang, J. and Zhou, C. (2022) Differential Transcriptional Profiles of Human Cumulus Granulosa Cells in Patients with Diminished Ovarian Reserve. Archives of Gynecology and Obstetrics, 305, 1605-1614. [Google Scholar] [CrossRef] [PubMed]
[4] 罗希, 赵淑云, 黄永俐, 等. 两种促排卵方案用于卵巢储备功能下降患者的自身对照研究[J]. 中国妇产科临床杂志, 2021, 22(6): 575-578.
[5] 卵巢储备功能减退临床诊治专家共识专家组, 中华预防医学会生育力保护分会生殖内分泌生育保护学组. 卵巢储备功能减退临床诊治专家共识[J]. 生殖医学杂志, 2022, 31(4): 425-434.
[6] 车祺, 董曦. 卵巢储备功能低下的诊治进展[J]. 实用妇产科杂志, 2024, 40(7): 517-519.
[7] 聂丽娜, 唐志霞, 洪名云. 卵巢低反应患者微刺激与拮抗剂方案促排卵结局和妊娠临床结局比较[J]. 中国药业, 2024, 33(15): 92-95.
[8] 欧玲, 张辉娟, 李婷. 不同促排卵方案应用于卵巢储备功能减退患者中的效果分析[J]. 中外医疗, 2024, 43(20): 33-36, 41.
[9] 赵梦思. 卵巢储备功能减退患者在IVF/ICSI中微刺激方案与自然周期方案的比较[J]. 实用妇科内分泌电子杂志, 2020, 7(1): 20-21.
[10] 吴静, 漆倩荣, 谢青贞. 拮抗剂方案用于前次IVF/ICSI-ET失败卵巢储备功能减退患者的自身对照研究[J]. 生殖医学杂志, 2024, 33(8): 991-996.
[11] 厉彦平. 不同超促排卵方案对多囊卵巢综合征患者应用效果评价[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2023.
[12] 侯金伟, 孙振高, 姜文晶, 等. 灵活低剂量拮抗剂方案对IVF/ICSI临床结局影响的回顾性分析[J]. 生殖医学杂志, 2022, 31(3): 296-301.
[13] 中国女医师协会生殖医学专业委员会专家共识编写组. 辅助生殖领域拮抗剂方案标准化应用专家共识[J]. 中华生殖与避孕杂志, 2022, 42(2): 109-116.
[14] 许定飞. GnRH拮抗剂方案影响人子宫内膜容受性的作用机制研究[D]: [博士学位论文]. 南昌: 南昌大学, 2022.
[15] 刘冬梅, 盖增鑫, 王志敏, 等. 促性腺激素释放激素拮抗剂方案和激动剂长方案在卵巢储备功能正常不孕患者中的应用效果比较[J]. 陕西医学杂志, 2024, 53(9): 1232-1235.
[16] 刘莉, 吴彩云, 管凌芳, 等. PCOS患者GnRH-ant方案促排卵过程E2水平变化对助孕结局的影响[J]. 安徽医科大学学报, 2024, 59(6): 961-965.
[17] 姜春榕. 黄体期长方案与拮抗剂方案在高龄不同卵巢储备人群中的应用比较[D]: [硕士学位论文]. 昆明: 昆明医科大学, 2023.
[18] 房丽娜, 王德佳, 李妍仪, 等. 改良长效长方案与拮抗剂方案对卵巢储备功能减退患者子宫内膜容受性的影响对比[J]. 中国计划生育和妇产科, 2024, 16(6): 49-52.
[19] 覃璧, 韦霁芸, 石德敏, 等. 不同促排卵方案在子宫内膜异位症合并不孕患者体外受精治疗中的效果比较[J]. 医学信息, 2022, 35(8): 118-120.
[20] Kuang, Y., Chen, Q., Fu, Y., Wang, Y., Hong, Q., Lyu, Q., et al. (2015) Medroxyprogesterone Acetate Is an Effective Oral Alternative for Preventing Premature Luteinizing Hormone Surges in Women Undergoing Controlled Ovarian Hyperstimulation for in Vitro Fertilization. Fertility and Sterility, 104, 62-70.e3. [Google Scholar] [CrossRef] [PubMed]
[21] Xu, S., Wang, X., Zhang, Y., Han, Y. and Zhang, C. (2023) Comparison the Effects of Progestin-Primed Ovarian Stimulation (PPOS) Protocol and GnRH-a Long Protocol in Patients with Normal Ovarian Reserve Function. Gynecological Endocrinology, 39, 1-5. [Google Scholar] [CrossRef] [PubMed]
[22] Zhang, S., Yin, Y., Li, Q. and Zhang, C. (2021) Comparison of Cumulative Live Birth Rates between Gnrh-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study. Frontiers in Endocrinology, 12, Article ID: 644456. [Google Scholar] [CrossRef] [PubMed]
[23] Pai, A.H., Sung, Y.J., Li, C., Lin, C.Y. and Chang, C.L. (2023) Progestin Primed Ovarian Stimulation (PPOS) Protocol Yields Lower Euploidy Rate in Older Patients Undergoing IVF. Reproductive Biology and Endocrinology, 21, Article No. 72. [Google Scholar] [CrossRef] [PubMed]
[24] Kao, T., Hsieh, Y., Yang, I., Wu, M., Chen, M., Yang, J., et al. (2023) Progestin-Primed Ovarian Stimulation versus Gnrh Antagonist Protocol in Poor Responders: Risk of Premature LH Surge and Outcome of Oocyte Retrieval. Journal of the Formosan Medical Association, 122, 29-35. [Google Scholar] [CrossRef] [PubMed]
[25] von Wolff, M. (2019) The Role of Natural Cycle IVF in Assisted Reproduction. Best Practice & Research Clinical Endocrinology & Metabolism, 33, 35-45. [Google Scholar] [CrossRef] [PubMed]
[26] Bosch, E., Broer, S., Griesinger, G., Grynberg, M., Humaidan, P., Kolibianakis, E., et al. (2020) Erratum: ESHRE Guideline: Ovarian Stimulation for IVF/ICSI. Human Reproduction Open, 2020, hoaa067. [Google Scholar] [CrossRef] [PubMed]
[27] 李阳, 张娟. 卵巢储备功能减退促排卵优化策略的研究进展[J]. 联勤军事医学, 2024, 38(6): 540-543.

为你推荐